Promoter methylation correlates with reduced NDRG2expression in advanced colon tumour
Open Access
- 3 March 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medical Genomics
- Vol. 2 (1), 11
- https://doi.org/10.1186/1755-8794-2-11
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinomaBMC Cancer, 2007
- Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell linesBiochemical and Biophysical Research Communications, 2007
- Quantitative DNA Methylation Analysis: The Promise of High-Throughput Epigenomic Diagnostic Testing in Human Neoplastic DiseaseThe Journal of Molecular Diagnostics, 2006
- Mechanisms of Mineralocorticoid ActionHypertension, 2005
- The history of cancer epigeneticsNature Reviews Cancer, 2004
- Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissueInternational Journal of Colorectal Disease, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Biostatistics: A Methodology for the Health Sciences.Journal of the Royal Statistical Society Series A: Statistics in Society, 1994
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Hypomethylation of ras oncogenes in primary human cancersBiochemical and Biophysical Research Communications, 1983